188 related articles for article (PubMed ID: 20946629)
1. Spermine oxidase (SMO) activity in breast tumor tissues and biochemical analysis of the anticancer spermine analogues BENSpm and CPENSpm.
Cervelli M; Bellavia G; Fratini E; Amendola R; Polticelli F; Barba M; Federico R; Signore F; Gucciardo G; Grillo R; Woster PM; Casero RA; Mariottini P
BMC Cancer; 2010 Oct; 10():555. PubMed ID: 20946629
[TBL] [Abstract][Full Text] [Related]
2. Spermine oxidase SMO(PAOh1), Not N1-acetylpolyamine oxidase PAO, is the primary source of cytotoxic H2O2 in polyamine analogue-treated human breast cancer cell lines.
Pledgie A; Huang Y; Hacker A; Zhang Z; Woster PM; Davidson NE; Casero RA
J Biol Chem; 2005 Dec; 280(48):39843-51. PubMed ID: 16207710
[TBL] [Abstract][Full Text] [Related]
3. The role of the polyamine catabolic enzymes SSAT and SMO in the synergistic effects of standard chemotherapeutic agents with a polyamine analogue in human breast cancer cell lines.
Pledgie-Tracy A; Billam M; Hacker A; Sobolewski MD; Woster PM; Zhang Z; Casero RA; Davidson NE
Cancer Chemother Pharmacol; 2010 May; 65(6):1067-81. PubMed ID: 19727732
[TBL] [Abstract][Full Text] [Related]
4. Induction of human spermine oxidase SMO(PAOh1) is regulated at the levels of new mRNA synthesis, mRNA stabilization and newly synthesized protein.
Wang Y; Hacker A; Murray-Stewart T; Fleischer JG; Woster PM; Casero RA
Biochem J; 2005 Mar; 386(Pt 3):543-7. PubMed ID: 15496143
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of N-alkylated spermine analogues by polyamine and spermine oxidases.
Häkkinen MR; Hyvönen MT; Auriola S; Casero RA; Vepsäläinen J; Khomutov AR; Alhonen L; Keinänen TA
Amino Acids; 2010 Feb; 38(2):369-81. PubMed ID: 20012116
[TBL] [Abstract][Full Text] [Related]
6. Biochemical evaluation of the anticancer potential of the polyamine-based nanocarrier Nano11047.
Murray-Stewart T; Ferrari E; Xie Y; Yu F; Marton LJ; Oupicky D; Casero RA
PLoS One; 2017; 12(4):e0175917. PubMed ID: 28423064
[TBL] [Abstract][Full Text] [Related]
7. Probing mammalian spermine oxidase enzyme-substrate complex through molecular modeling, site-directed mutagenesis and biochemical characterization.
Tavladoraki P; Cervelli M; Antonangeli F; Minervini G; Stano P; Federico R; Mariottini P; Polticelli F
Amino Acids; 2011 Apr; 40(4):1115-26. PubMed ID: 20839014
[TBL] [Abstract][Full Text] [Related]
8. Properties of purified recombinant human polyamine oxidase, PAOh1/SMO.
Wang Y; Murray-Stewart T; Devereux W; Hacker A; Frydman B; Woster PM; Casero RA
Biochem Biophys Res Commun; 2003 May; 304(4):605-11. PubMed ID: 12727196
[TBL] [Abstract][Full Text] [Related]
9. The Glu²¹⁶/Ser²¹⁸ pocket is a major determinant of spermine oxidase substrate specificity.
Cervelli M; Angelucci E; Stano P; Leboffe L; Federico R; Antonini G; Mariottini P; Polticelli F
Biochem J; 2014 Aug; 461(3):453-9. PubMed ID: 24854736
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of N1,N11-bis(ethyl)norspermine against human melanoma xenografts and possible biochemical correlates of drug action.
Porter CW; Bernacki RJ; Miller J; Bergeron RJ
Cancer Res; 1993 Feb; 53(3):581-6. PubMed ID: 8425191
[TBL] [Abstract][Full Text] [Related]
11. Increased breast cancer cell toxicity by palladination of the polyamine analogue N (1),N (11)-bis(ethyl)norspermine.
Silva TM; Fiuza SM; Marques MP; Persson L; Oredsson S
Amino Acids; 2014 Feb; 46(2):339-52. PubMed ID: 24363201
[TBL] [Abstract][Full Text] [Related]
12. Spermine oxidase: ten years after.
Cervelli M; Amendola R; Polticelli F; Mariottini P
Amino Acids; 2012 Feb; 42(2-3):441-50. PubMed ID: 21809080
[TBL] [Abstract][Full Text] [Related]
13. Polyamine catabolism in colorectal cancer cells following treatment with oxaliplatin, 5-fluorouracil and N1, N11 diethylnorspermine.
Hector S; Tummala R; Kisiel ND; Diegelman P; Vujcic S; Clark K; Fakih M; Kramer DL; Porter CW; Pendyala L
Cancer Chemother Pharmacol; 2008 Aug; 62(3):517-27. PubMed ID: 17987291
[TBL] [Abstract][Full Text] [Related]
14. Self-immolative polycations as gene delivery vectors and prodrugs targeting polyamine metabolism in cancer.
Zhu Y; Li J; Kanvinde S; Lin Z; Hazeldine S; Singh RK; Oupický D
Mol Pharm; 2015 Feb; 12(2):332-41. PubMed ID: 25153488
[TBL] [Abstract][Full Text] [Related]
15. Spermine metabolism and anticancer therapy.
Amendola R; Cervelli M; Fratini E; Polticelli F; Sallustio DE; Mariottini P
Curr Cancer Drug Targets; 2009 Mar; 9(2):118-30. PubMed ID: 19275753
[TBL] [Abstract][Full Text] [Related]
16. Discovery and antitumor evaluation of novel inhibitors of spermine oxidase.
Sun L; Yang J; Qin Y; Wang Y; Wu H; Zhou Y; Cao C
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1140-1151. PubMed ID: 31159606
[TBL] [Abstract][Full Text] [Related]
17. Polyamine analogue induction of programmed cell death in human lung tumor cells.
McCloskey DE; Yang J; Woster PM; Davidson NE; Casero RA
Clin Cancer Res; 1996 Mar; 2(3):441-6. PubMed ID: 9816189
[TBL] [Abstract][Full Text] [Related]
18. Induction of the PAOh1/SMO polyamine oxidase by polyamine analogues in human lung carcinoma cells.
Devereux W; Wang Y; Stewart TM; Hacker A; Smith R; Frydman B; Valasinas AL; Reddy VK; Marton LJ; Ward TD; Woster PM; Casero RA
Cancer Chemother Pharmacol; 2003 Nov; 52(5):383-90. PubMed ID: 12827295
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Pt-, Pd-spermine complexes for their effect on polyamine pathway and cisplatin resistance in A2780 ovarian carcinoma cells.
Tummala R; Diegelman P; Fiuza SM; Batista de Carvalho LA; Marques MP; Kramer DL; Clark K; Vujcic S; Porter CW; Pendyala L
Oncol Rep; 2010 Jul; 24(1):15-24. PubMed ID: 20514439
[TBL] [Abstract][Full Text] [Related]
20. Regulatory and antiproliferative effects of N-alkylated polyamine analogues in human and hamster pancreatic adenocarcinoma cell lines.
Chang BK; Bergeron RJ; Porter CW; Vinson JR; Liang Y; Libby PR
Cancer Chemother Pharmacol; 1992; 30(3):183-8. PubMed ID: 1628366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
